Fair Value Calculator Fair Value Calculator
EN DE

SIMPLEXCAS (SIMPLEXCAS) Fair Value & Analysis

IN · Market cap ₹4.4B

S SIMPLEXCAS SIMPLEXCAS · BSE
Price₹536.05
Fair Value₹518.56
Upside-3.3%
Quality48/100
Watch SIMPLEXCAS for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹384.39 – ₹648.20

Fair value as of: Jul 6, 2026

From 16 valuation models · updated today

Share price +9.8% over the past month.

Price vs Fair Value (12 months)

₹583.25 ₹360.20 Fair Value ₹518.56 Jul 2025 Jul 2026

12‑month range ₹360.20 – ₹583.25 · fair‑value band ₹384.39 – ₹648.20 · the ₹536.05 price screens above the ₹518.56 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SIMPLEXCAS (SIMPLEXCAS) currently trades at ₹536.05, while our model-based Fair Value estimate is ₹518.56 — implying the stock looks roughly 3.3% overvalued today. We read business quality at 48/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SIMPLEXCAS generated revenue of ₹2.0B at a net margin of 10.5%. Revenue declined 18.5% year over year. It earns a return on equity of 25.0%. Net debt stands at ₹494M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹384.39 (bear case) to ₹648.20 (bull case); at ₹536.05, the current price sits within that range. The share trades about 14% below its 52-week high and 50% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.0B
Revenue growth (YoY) -18.5%
Net margin 10.5%
Return on equity 25.0%
Free cash flow −₹58.7M FY2026
P/E ratio 19.0
More key figures
Operating margin 18.2%
EPS (TTM) ₹28.20
EPS growth (YoY) +61.5%
Net debt ₹494M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SIMPLEXCAS reported revenue of ₹2.0B in FY2026 versus ₹918M in FY2022, a compound +21.9%/yr. Reported net income was ₹213M in FY2026, compounding +93.3%/yr from FY2022.

Revenue +21.9%/yr
FY22 ₹918M
FY23 ₹1.2B
FY24 ₹1.2B
FY25 ₹1.7B
FY26 ₹2.0B
Net income +93.3%/yr
FY22 ₹15.2M
FY23 −₹170M
FY24 ₹23.9M
FY25 ₹151M
FY26 ₹213M

Is SIMPLEXCAS fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SIMPLEXCAS Fair Value". https://www.fairvalue-calculator.com/stock/SIMPLEXCAS

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SIMPLEXCAS (SIMPLEXCAS) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹518.56 versus a price of ₹536.05 — about −3% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SIMPLEXCAS?
Our model-based fair value for SIMPLEXCAS is ₹518.56 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹536.05.
What is the quality score of SIMPLEXCAS?
SIMPLEXCAS has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SIMPLEXCAS (SIMPLEXCAS)?
SIMPLEXCAS reported trailing-twelve-month revenue of about ₹2.0B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SIMPLEXCAS?
The net profit margin of SIMPLEXCAS is about 10.5%, meaning it keeps roughly 10.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.